Bioscience Americas has harnessed more than $400 million and more than fifteen years of adult stem cell research and treatment experience to make it available to patients worldwide. In partnering with the BioXcellerator, our efforts are focused on building stem cell rejuvenation and regeneration wellness centers in South America to serve both the South American and North American markets. Our vision is to open wellness centers on all five continents. Our association with Bioxcellerator continues to benefit from more than $50 million annually in research grants, endowment contributions, and legislative appropriations. This financial commitment assures that on-going research will continue to enable the Bioscience Americas and BioXcellerator team to provide the latest in FDA approved treatment protocols and clinical trial participation.
Looking for a particular Bioscience Americas employee's phone or email?
The Bioscience Americas annual revenue was $8 million in 2026.
Bioscience Americas is based in Phoenix, Arizona.
The NAICS codes for Bioscience Americas are [5417, 54, 541].
The SIC codes for Bioscience Americas are [28, 283].